Diffusion MRI for Quantitative Assessment of Myofascial Pain
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Mar 17, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women 18-65 years of age
- • Ability to give informed consent
- • Symptoms meeting criteria for normal or latent/active temporomandibular myofascial pain
- Exclusion Criteria:
- • Contraindications to MRI scanning including severe obesity or difficulty in laying in a supine position, intracranial clips, metal implants, external metallic devices/objects/clips within 10mm of the head, suspected or confirmed metal in the eyes (history of welding or similar activity), claustrophobia, cardiac pacemaker or pacing wires
- • Pregnancy or breast feeding
- • Dental implants with metal on the same side of the temporomandibular pain
- • Traumatic injury of masticatory muscles or temporomandibular joint within last 12 months
- • Mandibular fracture within last 12 months
- • Initiation of additional treatment of myofascial pain within the past 1 month
Trial Officials
Gene Kim, PhD
Principal Investigator
Weill Medical College of Cornell University
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
New York City, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported